BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 36996049)

  • 21. Lymphocytosis and lymphadenopathy in a dog arising from two distinct lymphoid neoplasms.
    Long ME; Evans B; Avery AC; Wellman ML
    Vet Clin Pathol; 2020 Jun; 49(2):307-311. PubMed ID: 32347563
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Species-specific properties and translational aspects of canine dendritic cells.
    Qeska V; Baumgärtner W; Beineke A
    Vet Immunol Immunopathol; 2013 Feb; 151(3-4):181-92. PubMed ID: 23280245
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic role of non-neoplastic lymphocytes in lymph node aspirates from dogs with diffuse large B-cell lymphoma treated with chemo-immunotherapy.
    Martini V; Aresu L; Riondato F; Marconato L; Cozzi M; Stefanello D; Comazzi S
    Res Vet Sci; 2019 Aug; 125():130-135. PubMed ID: 31212200
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD45+ and CD45- lymphocyte populations identified by flow cytometry from dogs with lymphoma exhibit similar morphology and the same clonal (B cell or T cell) lineage.
    Fogle JE; Tarigo JL; Thalheim L; Williams LE; English LB; Suter SE
    Vet Immunol Immunopathol; 2015 Dec; 168(3-4):242-8. PubMed ID: 26553299
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Affinity of the alpha4-beta1 integrin-targeting peptide LLP2A to canine lymphoma.
    Zwingenberger AL; Kent MS; Shi C; Taylor SL; Chen X; Lam KS
    Vet Immunol Immunopathol; 2012 Jan; 145(1-2):298-304. PubMed ID: 22177114
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical applications of monitoring immune status with 90 immune cell subsets in human whole blood by 10-color flow cytometry.
    Wang W; Li H; Zhang L; Jiang W; Shen L; Fan G
    Int J Lab Hematol; 2021 Oct; 43(5):1132-1144. PubMed ID: 33870648
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Possibilities of flow cytometric analysis for immunophenotypic characterization of canine lymphoma.
    Culmsee K; Simon D; Mischke R; Nolte I
    J Vet Med A Physiol Pathol Clin Med; 2001 May; 48(4):199-206. PubMed ID: 11413979
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PD-1 expression by canine T cells and functional effects of PD-1 blockade.
    Coy J; Caldwell A; Chow L; Guth A; Dow S
    Vet Comp Oncol; 2017 Dec; 15(4):1487-1502. PubMed ID: 28120417
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Using Full-Spectrum Flow Cytometry to Phenotype Memory T and NKT Cell Subsets with Optimized Tissue-Specific Preparation Protocols.
    Farrand K; Holz LE; Ferrer-Font L; Wilson MD; Ganley M; Minnell JJ; Tang CW; Painter GF; Heath WR; Hermans IF; Burn OK
    Curr Protoc; 2022 Jul; 2(7):e482. PubMed ID: 35819836
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of immune repertoire sequencing to resolve discordant microscopic and immunochemical findings in a case of T cell-rich large B cell lymphoma in a young dog.
    Lee GKC; Bienzle D; Keller SM; Hwang MH; Darzentas N; Chang H; Rätsep E; Egan R; Beeler-Marfisi J
    BMC Vet Res; 2021 Feb; 17(1):85. PubMed ID: 33602231
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Canine peripheral blood lymphocyte phenotyping by 7-color multiparameter flow cytometry.
    Platt R; Ng T; Glover S; Roof M; Kimura K; Roth JA
    Anal Quant Cytopathol Histpathol; 2013 Aug; 35(4):197-204. PubMed ID: 24341122
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An allogeneic hybrid-cell fusion vaccine against canine mammary cancer.
    Bird RC; Deinnocentes P; Lenz S; Thacker EE; Curiel DT; Smith BF
    Vet Immunol Immunopathol; 2008 Jun; 123(3-4):289-304. PubMed ID: 18423623
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Canine cancer immunotherapy studies: linking mouse and human.
    Park JS; Withers SS; Modiano JF; Kent MS; Chen M; Luna JI; Culp WTN; Sparger EE; Rebhun RB; Monjazeb AM; Murphy WJ; Canter RJ
    J Immunother Cancer; 2016; 4():97. PubMed ID: 28031824
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transient cell-in-cell formation underlies tumor relapse and resistance to immunotherapy.
    Gutwillig A; Santana-Magal N; Farhat-Younis L; Rasoulouniriana D; Madi A; Luxenburg C; Cohen J; Padmanabhan K; Shomron N; Shapira G; Gleiberman A; Parikh R; Levy C; Feinmesser M; Hershkovitz D; Zemser-Werner V; Zlotnik O; Kroon S; Hardt WD; Debets R; Reticker-Flynn NE; Rider P; Carmi Y
    Elife; 2022 Sep; 11():. PubMed ID: 36124553
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monitoring of large B-cell lymphoma and T-zone lymphoma in a dog via flow cytometry.
    Rosenbaum CS; Seelig DM; Burton EN; Gwynn AD; Granick J; Able HR
    J Vet Diagn Invest; 2021 Sep; 33(5):1008-1012. PubMed ID: 34176384
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor-immune profiling of murine syngeneic tumor models as a framework to guide mechanistic studies and predict therapy response in distinct tumor microenvironments.
    Yu JW; Bhattacharya S; Yanamandra N; Kilian D; Shi H; Yadavilli S; Katlinskaya Y; Kaczynski H; Conner M; Benson W; Hahn A; Seestaller-Wehr L; Bi M; Vitali NJ; Tsvetkov L; Halsey W; Hughes A; Traini C; Zhou H; Jing J; Lee T; Figueroa DJ; Brett S; Hopson CB; Smothers JF; Hoos A; Srinivasan R
    PLoS One; 2018; 13(11):e0206223. PubMed ID: 30388137
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exclusion of cytoplasmic fragments in flow cytometric analysis of lymph node samples from dogs with lymphoma using membrane-permeable violet laser-excitable DNA-binding fluorescent dye (DyeCycle Violet).
    Ito D; O'Brien TD; Modiano JF
    Vet Clin Pathol; 2010 Dec; 39(4):494-8. PubMed ID: 21198735
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Utility of flow cytometry in canine primary cutaneous and matched nodal mast cell tumor.
    Sulce M; Marconato L; Martano M; Iussich S; Dentini A; Melega M; Miniscalco B; Riondato F
    Vet J; 2018 Dec; 242():15-23. PubMed ID: 30503539
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of acute myeloid leukemia in dogs using flow cytometry with myeloperoxidase, MAC387, and a canine neutrophil-specific antibody.
    Villiers E; Baines S; Law AM; Mallows V
    Vet Clin Pathol; 2006 Mar; 35(1):55-71. PubMed ID: 16511792
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Loss of CD45 cell surface expression in canine T-zone lymphoma results from reduced gene expression.
    Martini V; Cozzi M; Aricò A; Dalla Rovere G; Poggi A; Albonico F; Mortarino M; Ciusani E; Aresu L; Comazzi S
    Vet Immunol Immunopathol; 2017 May; 187():14-19. PubMed ID: 28494924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.